These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15974985)

  • 1. Structural requirements for binding of myelin basic protein (MBP) peptides to MHC II: effects on immune regulation.
    Mantzourani ED; Mavromoustakos TM; Platts JA; Matsoukas JM; Tselios TV
    Curr Med Chem; 2005; 12(13):1521-35. PubMed ID: 15974985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen.
    Nag B; Deshpande SV; Sharma SD; Clark BR
    J Biol Chem; 1993 Jul; 268(19):14360-6. PubMed ID: 7686154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structural interactions between T cell receptors and MHC-peptide complexes place physical limits on self-nonself discrimination.
    Wucherpfennig KW
    Curr Top Microbiol Immunol; 2005; 296():19-37. PubMed ID: 16329190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.
    Li Y; Huang Y; Lue J; Quandt JA; Martin R; Mariuzza RA
    EMBO J; 2005 Sep; 24(17):2968-79. PubMed ID: 16079912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.
    Fridkis-Hareli M; Teitelbaum D; Gurevich E; Pecht I; Brautbar C; Kwon OJ; Brenner T; Arnon R; Sela M
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4872-6. PubMed ID: 7515181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculations.
    Tzakos AG; Fuchs P; van Nuland NA; Troganis A; Tselios T; Deraos S; Matsoukas J; Gerothanassis IP; Bonvin AM
    Eur J Biochem; 2004 Aug; 271(16):3399-413. PubMed ID: 15291817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity.
    Maynard J; Petersson K; Wilson DH; Adams EJ; Blondelle SE; Boulanger MJ; Wilson DB; Garcia KC
    Immunity; 2005 Jan; 22(1):81-92. PubMed ID: 15664161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 3A6-TCR/superagonist/HLA-DR2a complex shows similar interface and reduced flexibility compared to the complex with self-peptide.
    Salutari I; Martin R; Caflisch A
    Proteins; 2020 Jan; 88(1):31-46. PubMed ID: 31237711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation of experimental autoimmune encephalomyelitis with ordered peptides based on MHC-TCR binding motifs.
    Ruiz PJ; DeVoss JJ; Nguyen LV; Fontoura PP; Hirschberg DL; Mitchell DJ; Garcia KC; Steinman L
    J Immunol; 2001 Sep; 167(5):2688-93. PubMed ID: 11509612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis.
    Gautam AM; Pearson CI; Smilek DE; Steinman L; McDevitt HO
    J Exp Med; 1992 Aug; 176(2):605-9. PubMed ID: 1380066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.
    Muraro PA; Vergelli M; Kalbus M; Banks DE; Nagle JW; Tranquill LR; Nepom GT; Biddison WE; McFarland HF; Martin R
    J Clin Invest; 1997 Jul; 100(2):339-49. PubMed ID: 9218510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of T cells by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules.
    McConnell HM; Wada HG; Arimilli S; Fok KS; Nag B
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2750-4. PubMed ID: 7708718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.
    Wucherpfennig KW; Strominger JL
    Cell; 1995 Mar; 80(5):695-705. PubMed ID: 7534214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-linked oligosaccharides of murine major histocompatibility complex class II molecule. Role in antigenic peptide binding, T cell recognition, and clonal nonresponsiveness.
    Nag B; Passmore D; Kendrick T; Bhayani H; Sharma SD
    J Biol Chem; 1992 Nov; 267(31):22624-9. PubMed ID: 1385402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimum structural requirements for peptide presentation by major histocompatibility complex class II molecules: implications in induction of autoimmunity.
    Gautam AM; Lock CB; Smilek DE; Pearson CI; Steinman L; McDevitt HO
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):767-71. PubMed ID: 7507253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW; Hafler DA; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing.
    Vergelli M; Pinet V; Vogt AB; Kalbus M; Malnati M; Riccio P; Long EO; Martin R
    Eur J Immunol; 1997 Apr; 27(4):941-51. PubMed ID: 9130648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
    Zang YC; Li S; Rivera VM; Hong J; Robinson RR; Breitbach WT; Killian J; Zhang JZ
    J Immunol; 2004 Apr; 172(8):5120-7. PubMed ID: 15067096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.